Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Medicinal Chemicals & Botanical Products

Standard Industrial Classification: SIC 2833

Industry Insider Sentiment Analysis

The Medicinal Chemicals & Botanical Products sector (SIC 2833) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2024-06-05 01:03 2024-05-31 FTLF FITLIFE BRANDS, INC. Ryan Patrick John Phillip Officer SELL $31.80 10,544 $335,336 0
2024-06-05 00:00 2024-05-31 CHUC Charlie's Holdings, Inc. King Michael D Director BUY $0.08 1,250,000 $100,000 6,050,001
2024-05-23 20:03 2024-05-22 USNA USANA HEALTH SCIENCES INC Jones Paul A. Officer SELL $48.66 2,714 $132,064 6,266
2024-05-23 18:40 2024-05-22 MTEX MANNATECH INC JOBE LARRY A Director SELL $7.60 1,012 $7,691 71,009
2024-05-21 01:30 2024-05-16 TRUL Trulieve Cannabis Corp. Alvarez Giannella Director SELL $12.76 1,072 $13,678 44,732
2024-05-08 02:43 2024-05-07 USNA USANA HEALTH SCIENCES INC IIEKKING G DOUG Officer SELL $44.76 5,198 $232,677 0
2024-05-07 23:08 2024-05-07 USNA USANA HEALTH SCIENCES INC FULLER GILBERT A Director SELL $44.59 490 $21,849 0
2024-05-02 23:18 2024-05-02 USNA USANA HEALTH SCIENCES INC Macuga Daniel A. Officer SELL $47.14 3,791 $178,717 0
2024-04-30 02:07 2024-04-29 MRMD MARIMED INC. Shaw Timothy Officer OPT+S $0.26 40,205 $10,264 8,547,978
2024-04-30 00:36 2024-04-29 MRMD MARIMED INC. Levine Jon R Director, Officer OPT+S $0.26 50,031 $12,773 20,317,878
2024-03-27 00:15 2024-03-25 MNMD Definium Therapeutics, Inc. Karlin Dan Officer SELL $9.50 6,578 $62,491 358,452
2024-03-27 00:15 2024-03-25 MNMD Definium Therapeutics, Inc. Barrow Robert Director, Officer SELL $9.50 16,519 $156,931 580,202
2024-03-11 21:22 2024-03-08 USNA USANA HEALTH SCIENCES INC Noot Walter Officer SELL $49.05 5,240 $257,022 0
2024-03-12 00:30 2024-03-07 MRMD MARIMED INC. Shaw Timothy Officer OPT+S $0.23 15,348 $3,604 8,477,072
2024-03-12 00:05 2024-03-07 MRMD MARIMED INC. Levine Jon R Director, Officer OPT+S $0.23 16,529 $3,881 20,229,020
2024-03-11 21:26 2024-03-11 USNA USANA HEALTH SCIENCES INC Guest Kevin Officer SELL $49.00 11,011 $539,539 10,491
2024-03-07 19:50 2024-03-06 USNA USANA HEALTH SCIENCES INC Neidig Brent Officer SELL $47.00 3,810 $179,066 0
2024-03-05 20:36 2024-03-04 USNA USANA HEALTH SCIENCES INC Fleming John Turman Director SELL $48.99 300 $14,696 3,013
2024-03-06 02:28 2024-03-05 USNA USANA HEALTH SCIENCES INC SINNOTT ROBERT A Officer SELL $46.56 3,945 $183,659 0
2024-03-05 20:28 2024-03-04 USNA USANA HEALTH SCIENCES INC FULLER GILBERT A Director SELL $49.07 491 $24,096 0
2024-03-05 00:40 2024-02-29 USNA USANA HEALTH SCIENCES INC Pelosi Peggie Director SELL $48.15 485 $23,351 3,138
2024-03-04 19:58 2024-02-29 USNA USANA HEALTH SCIENCES INC Foukas Joshua Officer SELL $47.91 4,847 $232,234 0
2024-03-04 20:05 2024-02-29 USNA USANA HEALTH SCIENCES INC Mulham David Mulham Officer SELL $47.76 4,311 $205,872 7,825
2024-03-04 20:11 2024-03-01 USNA USANA HEALTH SCIENCES INC Macuga Daniel A. Officer SELL $48.08 1,500 $72,120 3,791
2024-02-27 22:56 2024-02-26 CYAN CYANOTECH CORP Jensen Glenn Officer BUY $0.31 16,835 $5,222 17,210
2024-01-18 16:32 2024-01-17 TLRY Tilray Brands, Inc. FALTISCHEK DENISE M Officer BUY $2.05 10,000 $20,500 293,269
2024-01-16 21:07 2024-01-16 TLRY Tilray Brands, Inc. Gendel Mitchell Officer BUY $1.98 7,200 $14,256 195,796
2024-01-12 23:36 2024-01-12 TLRY Tilray Brands, Inc. SIMON IRWIN D Officer BUY $1.88 53,700 $100,956 2,033,058
2024-01-12 23:36 2024-01-12 TLRY Tilray Brands, Inc. Merton Carl A Officer BUY $1.87 20,000 $37,400 20,000
2024-01-12 23:39 2024-01-12 TLRY Tilray Brands, Inc. Gendel Mitchell Officer BUY $1.87 5,400 $10,098 188,596
2024-01-03 02:34 2023-12-29 CGC Canopy Growth Corp Yanofsky Theresa Director SELL $6.68 3,697 $24,696 17,501
2024-01-03 02:33 2023-12-29 CGC Canopy Growth Corp Lazzarato David Angelo Director SELL $6.68 3,713 $24,803 17,042
2023-12-27 00:59 2023-12-26 MNMD Definium Therapeutics, Inc. Karlin Dan Officer SELL $3.63 6,774 $24,590 365,030
2023-12-27 00:50 2023-12-26 MNMD Definium Therapeutics, Inc. Barrow Robert Director, Officer SELL $3.63 13,237 $48,050 596,721
2023-12-27 00:44 2023-12-26 MNMD Definium Therapeutics, Inc. Greenway Schond L. Officer SELL $3.63 5,652 $20,517 216,617
2023-12-20 00:18 2023-12-15 FTLF FITLIFE BRANDS, INC. Ryan Patrick John Phillip Officer SELL $24.50 4,000 $98,000 10,544
2023-12-20 00:17 2023-12-15 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $1.00 400,000 $400,000 1,046,736
2023-12-14 22:07 2023-12-12 USNA USANA HEALTH SCIENCES INC Fleming John Turman Director SELL $49.73 312 $15,515 2,822
2023-12-05 00:12 2023-12-01 CDXC Niagen Bioscience, Inc. Gerber Brianna Officer BUY $1.41 5,000 $7,050 27,436
2023-12-04 23:35 2023-12-01 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $0.90 39,455 $35,510 646,736
2023-12-05 00:27 2023-12-01 CHUC Charlie's Holdings, Inc. Carmines Edward Director BUY $0.09 17,498 $1,575 1,661,758
2023-11-23 00:03 2023-11-20 CGC Canopy Growth Corp Lazzarato David Angelo Director SELL $0.81 38,502 $31,187 207,562
2023-11-23 00:02 2023-11-20 CGC Canopy Growth Corp Yanofsky Theresa Director SELL $0.81 38,344 $31,059 211,991
2023-11-23 00:01 2023-11-20 CGC Canopy Growth Corp SCHMELING JUDY Director SELL $0.81 18,481 $14,970 420,541
2023-11-07 23:22 2023-11-03 USNA USANA HEALTH SCIENCES INC FULLER GILBERT A Director SELL $46.01 490 $22,546 0
2023-10-31 00:24 2023-10-27 MRMD MARIMED INC. Levine Jon R Director, Officer, 10% owner OPT+S $0.32 41,590 $13,350 20,198,882
2023-10-31 00:17 2023-10-27 MRMD MARIMED INC. Shaw Timothy Officer OPT+S $0.32 33,272 $10,680 8,449,087
2023-09-26 04:30 2023-09-25 MNMD Definium Therapeutics, Inc. Barrow Robert Director, Officer SELL $3.58 13,499 $48,274 611,729
2023-09-26 04:30 2023-09-25 MNMD Definium Therapeutics, Inc. Karlin Dan Officer SELL $3.57 6,918 $24,730 371,804
2023-09-26 04:30 2023-09-25 MNMD Definium Therapeutics, Inc. Greenway Schond L. Officer SELL $3.58 5,762 $20,609 222,269
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Medicinal Chemicals & Botanical Products sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2833) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Medicinal Chemicals & Botanical Products

Every transaction in the Medicinal Chemicals & Botanical Products industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.